{"id":"https://openalex.org/W2014263279","doi":"https://doi.org/10.1111/j.1365-2125.1995.tb04502.x","title":"Effect of tenidap sodium on digoxin pharmacokinetics in healthy young men.","display_name":"Effect of tenidap sodium on digoxin pharmacokinetics in healthy young men.","publication_year":1995,"publication_date":"1995-02-01","ids":{"openalex":"https://openalex.org/W2014263279","doi":"https://doi.org/10.1111/j.1365-2125.1995.tb04502.x","mag":"2014263279","pmid":"https://pubmed.ncbi.nlm.nih.gov/7547094","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1364936"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2125.1995.tb04502.x","doi":"https://doi.org/10.1111/j.1365-2125.1995.tb04502.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1995.tb04502.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1995.tb04502.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1995.tb04502.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000449175","display_name":"Peter M. Dewland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267803","display_name":"Simbec Research Ltd. (United Kingdom)","ror":"https://ror.org/04er29560","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405267803"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"PM Dewland","raw_affiliation_strings":["Simbec Research Centre Ltd, Mid Glamorgan, Wales, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simbec Research Centre Ltd, Mid Glamorgan, Wales, UK","institution_ids":["https://openalex.org/I4405267803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026339061","display_name":"VC Grimwood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267803","display_name":"Simbec Research Ltd. (United Kingdom)","ror":"https://ror.org/04er29560","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405267803"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"VC Grimwood","raw_affiliation_strings":["Simbec Research Centre Ltd, Mid Glamorgan, Wales, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simbec Research Centre Ltd, Mid Glamorgan, Wales, UK","institution_ids":["https://openalex.org/I4405267803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111411889","display_name":"WG Rapeport","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267803","display_name":"Simbec Research Ltd. (United Kingdom)","ror":"https://ror.org/04er29560","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405267803"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"WG Rapeport","raw_affiliation_strings":["Simbec Research Centre Ltd, Mid Glamorgan, Wales, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simbec Research Centre Ltd, Mid Glamorgan, Wales, UK","institution_ids":["https://openalex.org/I4405267803"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111600671","display_name":"Peter E. Coates","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267803","display_name":"Simbec Research Ltd. (United Kingdom)","ror":"https://ror.org/04er29560","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405267803"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"PE Coates","raw_affiliation_strings":["Simbec Research Centre Ltd, Mid Glamorgan, Wales, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Simbec Research Centre Ltd, Mid Glamorgan, Wales, UK","institution_ids":["https://openalex.org/I4405267803"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405267803"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.12270093,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"39","issue":"S1","first_page":"43S","last_page":"46S"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.885699987411499,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.885699987411499,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.016899999231100082,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/digoxin","display_name":"digoxin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7940000295639038},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9200000166893005},{"id":"https://openalex.org/keywords/renal-clearance","display_name":"renal clearance","score":0.6019999980926514},{"id":"https://openalex.org/keywords/plasma-concentration-time-curve","display_name":"plasma concentration-time curve","score":0.6830000281333923},{"id":"https://openalex.org/keywords/time-to-maximum-concentration","display_name":"time to peak concentration","score":0.625},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6539999842643738},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.6330000162124634},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5770000219345093}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.872124195098877},{"id":"https://openalex.org/C2777707475","wikidata":"https://www.wikidata.org/wiki/Q422222","display_name":"Digoxin","level":3,"score":0.8105027675628662},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6246229410171509},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6047064661979675},{"id":"https://openalex.org/C537181965","wikidata":"https://www.wikidata.org/wiki/Q658","display_name":"Sodium","level":2,"score":0.4942910671234131},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3207417130470276},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2709978520870209},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.0629594624042511},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000078183","descriptor_name":"Oxindoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004077","descriptor_name":"Digoxin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004077","descriptor_name":"Digoxin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1365-2125.1995.tb04502.x","doi":"https://doi.org/10.1111/j.1365-2125.1995.tb04502.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1995.tb04502.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1995.tb04502.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1364936","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1364936","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:7547094","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7547094","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2125.1995.tb04502.x","doi":"https://doi.org/10.1111/j.1365-2125.1995.tb04502.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1995.tb04502.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1995.tb04502.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2014263279.pdf","grobid_xml":"https://content.openalex.org/works/W2014263279.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W118403110","https://openalex.org/W1529758829","https://openalex.org/W1855316965","https://openalex.org/W2026753073","https://openalex.org/W2027008543","https://openalex.org/W2081511956","https://openalex.org/W2084386397","https://openalex.org/W2088434993","https://openalex.org/W2418111932","https://openalex.org/W2465681543"],"related_works":["https://openalex.org/W2410659070","https://openalex.org/W2415167903","https://openalex.org/W2089940763","https://openalex.org/W1499620303","https://openalex.org/W2036680207","https://openalex.org/W1605274006","https://openalex.org/W1976367840","https://openalex.org/W2029910428","https://openalex.org/W2058896268","https://openalex.org/W2465900291"],"abstract_inverted_index":{"1.":[0],"The":[1,219],"effects":[2,242],"of":[3,138,158,204,221,231,247],"tenidap":[4,41,94,122,139,174,188,216,232],"sodium":[5],"and":[6,38,62,80,83,95,140,163,175,177,182,195,215,249],"placebo":[7,46,96],"on":[8,169,173,180,243],"digoxin":[9,31,39,86,116,141,170,181,214,234],"pharmacokinetics":[10],"were":[11,29,157,164,196,201],"compared":[12,124],"in":[13,18,54,108,198,226],"14":[14,50,119],"healthy":[15,227],"young":[16,228],"men,":[17,229],"a":[19,100],"double-blind,":[20],"parallel-group":[21],"study":[22,150,223],"lasting":[23],"for":[24,33,47,67],"24":[25,64],"days.":[26,51],"2.":[27],"Subjects":[28],"administered":[30],"alone":[32],"the":[34,48,55,72,77,81,93,109,149,187,192,244,250],"first":[35],"10":[36,59],"days":[37],"plus":[40],"120":[42],"mg":[43],"day-1":[44],"or":[45,208],"remaining":[49],"3.":[52],"Changes":[53],"means":[56],"between":[57,92],"day":[58,63],"(digoxin":[60],"monotherapy)":[61],"(combined":[65],"therapy)":[66],"renal":[68],"clearance,":[69],"area":[70],"under":[71],"plasma":[73,85,115],"concentration-time":[74],"curve":[75],"during":[76,151],"dosing":[78],"interval,":[79],"minimum":[82],"maximum":[84,114],"concentrations":[87],"did":[88],"not":[89,130,236],"differ":[90],"significantly":[91],"groups.":[97],"There":[98,200],"was":[99,129,142],"small":[101],"but":[102,127],"statistically":[103],"significant":[104,241],"increase":[105],"(0.5":[106],"h)":[107],"time":[110],"taken":[111],"to":[112,132,160,212],"reach":[113],"concentration":[117],"following":[118],"days'":[120],"continuous":[121],"co-administration":[123,230],"with":[125,233],"placebo,":[126],"this":[128,222],"considered":[131],"be":[133],"clinically":[134,240],"meaningful.":[135],"4.":[136],"Co-administration":[137],"well":[143,253],"tolerated.":[144,254],"No":[145],"subject":[146],"withdrew":[147],"from":[148],"combination":[152],"treatment.":[153],"Treatment-related":[154],"adverse":[155],"events":[156],"mild":[159,197],"moderate":[161],"severity":[162],"reported":[165,185],"by":[166,178,186],"four":[167,172],"subjects":[168],"monotherapy,":[171],"digoxin,":[176,248],"two":[179],"placebo.":[183],"Those":[184],"group":[189],"predominantly":[190],"affected":[191],"gastrointestinal":[193],"system":[194],"severity.":[199],"no":[202],"reports":[203],"laboratory":[205],"test":[206],"abnormalities":[207,210],"cardiovascular":[209],"related":[211],"combined":[213],"administration.":[217],"5.":[218],"results":[220],"indicate":[224],"that,":[225],"does":[235],"have":[237],"any":[238],"apparent":[239],"pharmacokinetic":[245],"profile":[246],"treatment":[251],"is":[252]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}